UK markets open in 2 hours 57 minutes

Achieve Life Sciences, Inc. (SP4P.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
4.6400+0.0200 (+0.43%)
At close: 08:08AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
25,970
15,814
30,078
23,966
6,882
-
Selling general and administrative
11,083
11,436
10,722
9,128
7,868
-
Total operating expenses
37,053
27,250
40,800
33,094
14,750
-
Operating income or loss
-37,053
-27,250
-40,800
-33,094
-14,750
-
Interest expense
3,093
2,853
1,789
0
0
-
Total other income/expenses net
-58
-537
40
-75
-49
-
Income before tax
-38,269
-29,815
-42,350
-33,152
-14,730
-
Income tax expense
-
-
-
-
-
0
Income from continuing operations
-38,269
-29,815
-42,350
-33,152
-14,730
-
Net income
-38,269
-29,815
-42,350
-33,152
-14,730
-
Net income available to common shareholders
-38,269
-29,815
-42,350
-33,152
-14,730
-
Basic EPS
-2.02
-
-4.00
-4.08
-5.42
-39.76
Diluted EPS
-2.02
-
-4.00
-4.08
-5.42
-39.76
Basic average shares
17,925
-
10,593
8,120
2,719
412.32
Diluted average shares
17,925
-
10,593
8,120
2,719
412.32